Data Monitoring Committee Determines Alnylam's ENDEAVOUR Trial May Continue
October 10, 2016 at 12:23 PM EDT
Morgan Stanley in a research note released Monday noted that the Data Monitoring Committee has recommended Alnylam Pharmaceuticals, ...